---
title: "Barclays maintains Viatris at Overweight, raises price target to $25 from $22"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305698258.md"
description: "Barclays maintained Viatris at Overweight and raised its price target to $25 from $22, a 13.6% increase.The price target implies an upside of 20.1% from the Nov 13 close of $20.82.Explore more price target data and ratings for Viatris on the , and track all previous and future analyst recommendations in the dedicated News Flow.DisclaimerSelect reference data provided by Benzinga. This information is not a recommendation for what you should do personally and does not constitute investment advice."
datetime: "2026-11-16T15:55:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305698258.md)
  - [en](https://longbridge.com/en/news/305698258.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305698258.md)
generator: "portal-rs"
---

# Barclays maintains Viatris at Overweight, raises price target to $25 from $22

Barclays maintained Viatris at Overweight and raised its price target to $25 from $22, a 13.6% increase.

The price target implies an upside of 20.1% from the Nov 13 close of $20.82.

Explore more price target data and ratings for Viatris on the , and track all previous and future analyst recommendations in the dedicated News Flow.

**Disclaimer**

Select reference data provided by Benzinga. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [VTRS.US](https://longbridge.com/en/quote/VTRS.US.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)

## Related News & Research

- [Viatris Completes Acquisition, Making Pacira a Wholly Owned Subsidiary](https://longbridge.com/en/news/305845437.md)
- [Viatris (VTRS) Stock Still Looks Cheap On Its 145% Rebound](https://longbridge.com/en/news/304742897.md)
- [VTRS: Complex generics, Pacira and pipeline readouts set up growth through 2027 and beyond](https://longbridge.com/en/news/305811980.md)
- [How Investors May Respond To Viatris (VTRS) Wider Quarterly Loss](https://longbridge.com/en/news/304506535.md)
- [Viatris Q3 adjusted EPS beats estimates; hikes forecast](https://longbridge.com/en/news/304449096.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**